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1. Introduction sponsible for a dysfunction of nitric oxide synthase leading
to a shift in the balance between the production of
Nitric oxide (NO) plays a crucial role in the regulation protective NO and deleterious oxygen-derived free radicals
of vascular tone and maintenance of vascular integrity (Fig. 1). Tetrahydrobiopterin is known to be a cofactor of
[1–3]. Indeed, nitric oxide reduces vascular tone, inhibits aromatic amino acid monooxygenases, which are regarded
leucocytes adhesion to the endothelium, platelet-vessel as key enzymes in the biosynthesis of several neuro-
wall interaction, as well as vascular smooth muscle cell transmitters, including catecholamines and serotonin [23].
proliferation and migration. Accordingly, major risk fac- It is indeed well established that inborn errors of tetrahy-
tors for atherosclerotic vascular disease such as hyper- drobiopterin metabolism lead to cofactor deficiency, hy-
cholesterolemia, diabetes, hypertension and smoking, have perphenylalaninemia, and neurological impairment [24]. In
been associated with impaired nitric oxide activity [4–11]. contrast, an important role of tetrahydrobiopterin in car-
In vivo the activity of the L-arginine-NO pathway is a diovascular system has been recognized only recently. The
balance between the synthesis and breakdown of NO. first step of tetrahydrobiopterin biosynthesis involves
Although, there are several reasons to believe that NO activation of guanosine triphosphate (GTP)-cyclohydrolase
synthesis could be impaired [12–14], reduced NO activity I, which catalyzes the conversion of GTP to dihydroneop-
could be caused by enhanced catabolism. Indeed, the in terin triphospahte [25]. Intracellular levels of tetrahydro-
vivo half-life of NO is determined mainly by its reaction biopterin can also be increased by treating cells or animals
with oxyhemoglobin and superoxide anion [15]. Superox- with sepiapterin, which is converted to tetrahydrobiopterin
2ide (O ) may rapidly react with NO to produce perox- via the so-called ‘salvage pathway’. This review will2
2ynitrite (OONO ; [16]). This reaction is even faster than briefly discuss the complex interaction between tetrahydro-
2the one of O with superoxide dismutase to form hydro- biopterin and nitric oxide synthase and its role in the2
gen peroxide (H O ) and molecular oxygen. High con- control of vascular tone.2 2
2 2
centrations of ONOO are very toxic, ONNO can form
peroxynitrous acid whose cleavage products are among the
most reactive and damaging species in biological systems 2. Effects of tetrahydrobiopterin on NOS activity
[17]. Taken together, these data indicate that catabolism of
NO by its reaction with superoxide could be an important NO is synthesized from L-arginine by nitric oxide
mechanism underlying endothelial dysfunction and oxida- synthase (NOS) through a five electron oxidation. Three
tive vascular injury described in a number of vascular distinct NOS isoforms have been identified by molecular
diseases [18,19]. It can be postulated that harmful con- cloning [26]. Two of them are expressed constitutively in
2
centrations of ONOO can be achieved in a dysfunctional neurones (neuronal) and vascular endothelial cells (endo-
2
endothelium in which O generation is increased by thelial) and are activated by increased intracellular calcium2
cyclooxygenase, xanthine oxidase, and NADH oxidoreduc- levels. The expression of a third isoform is induced, in a
tase [20–22]. However, recent evidence indicates that calcium-independent fashion, by various cytokines in
decreased availability of tetrahydrobiopterin may be re- macrophages and a number of other nucleated mammalian
cells including hepatocytes and vascular smooth muscle
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properly bound, but NO synthases do not. All three NOS
isoforms additionally require tetrahydrobiopterin for cata-
lytic activity. Tetrahydrobiopterin (H B) appears to medi-4
ate coupling of oxygen reduction to heme-catalyzed L-
arginine oxidation to form NO and L-citrulline, but the
molecular mechanism of this effect is still unknown. It
could involve either an allosteric effect on the NOS protein
or redox activity of H B, or both [25]. A close link4
between cellular H B availability and NO synthesis was4
recently demonstrated for a number of different cell types:
murine endothelial cells, vascular smooth muscle cells,
porcine and human endothelial cells, suggesting that the
pathways for H B and NO synthesis are tightly coupled4
[25]. Indeed, in porcine and human vascular endothelial
cells, inhibition of H B synthesis reduces production of4
NO in response to the calcium ionophore A23187 or
bradykinin [28,29]. These studies provided evidence that in
cultured endothelial cells, an optimal concentration of
tetrahydrobiopterin is essential for agonist-induced, cal-
cium-dependent production of nitric oxide.
Although, the precise role of this cofactor in regulation
of NOS catalytic activity is still not completely understood
[25], it has been postulated that H B plays an important4
role in whether the electron flow, within the enzyme, can
be directed to L-arginine. Indeed, several biochemical
Fig. 1. Schematic representation of nitric oxide synthase (NO synthase)
studies demonstrated that activation of purified constitutive
reaction leading to L-citrulline and nitric oxide (NO) from L-arginine and
NOS in the presence of suboptimal levels of tetrahydro-oxygen (O ) (top). The activation of NO synthase at suboptimal levels2
biopterin results in uncoupling of oxygen reduction and(dashed line) of (6R)-5,6,7,8-tetrahydrobiopterin (H Biopterin) generates4
2
superoxide anion (O ) followed by the production of hydrogen peroxide arginine oxidation, thereby generating superoxide anions2
2 2(H O ) and/or peroxynitrite (ONOO ) from the rapid reaction of O and2 2 2 and subsequently hydrogen peroxide [30–32]. In agree-
NO (bottom) (modified from ref. [38]).
ment with these results, we recently demonstrated that in
isolated canine coronary arteries depleted of tetrahydro-
(inducible). Purification and cloning of NOS isoforms have biopterin endothelial nitric oxide synthase may become a
revealed that they are self-sufficient one-component cyto- source of oxygen-free radicals [33]. Ever since, growing
chrome P-450s, which contain a prosthetic heme group evidence indicates that, under certain pathological con-
catalyzing the reductive activation of molecular oxygen ditions, decreased tetrahydrobiopterin availability may be
requisite for L-arginine oxidation, as well as tightly bound responsible for dysfunction of endothelial NOS.
flavins shuttling NADPH-derived electrons to the heme Very intriguing are recent findings showing that endo-
(Fig. 2; [27]). Classical cytochrome P-450 hydroxylating thelial cells that were incubated with LDL released
systems would operate perfectly with these cofactors being superoxide, which could be inhibited by the NOS inhibitor
Fig. 2. NO is produced by NOS, which incorporates molecular oxygen into the substrate L-arginine. The NOS itself has binding sites for
tetrahydrobiopterin (H B), L-arginine and heme. Electrons donated by reduced nicotinamide-adenine dinucleotide phosphate (NADPH) are shuttled through4
the reduced flavins, flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) toward the oxidase domain. The built-in electron transport
system is used to oxidize L-arginine to NO and L-citrulline. This reaction is dependent on the presence of H B.4
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L-NAME [34]. These data suggest that NOS itself can be sion injury [44]. Such effect of exogenous tetrahydro-
an important source for endothelial superoxide production biopterin is consistent with the concept of an altered
in hypercholesterolemia. Indeed, enhanced oxidative deg- tetrahydrobiopterin-NOS interaction which may lead to the
radation of NO is a major determinant of impaired NO above-mentioned dysfunctional activity of the enzyme.
activity in hypercholesterolemia [35–37]. Deficiency of Interestingly enough, an impaired synthesis of H B4
tetrahydrobiopterin causes both impaired NO activity and occurs in adrenal cortex of spontaneously hypertensive rats
increased oxygen radical formation [33,38]. In this regard, (SHR; [45]). This metabolic dysfunction was detected in
we further demonstrated that infusion of tetrahydrobiop- prehypertensive animals suggesting that it may contribute
terin into the brachial artery of patients with hypercholes- to the development of hypertension and/or its complica-
terolemia restores endothelial dysfunction by increasing tions. We reported [38] that in isolated aortas from
production of NO [39]. Therefore, increased breakdown of prehypertensive SHR, H B supplementation diminished4
nitric oxide could be explained from a decreased availabili- the NOS-dependent generation of superoxide and its
ty of tetrahydrobiopterin. Cofactor supplementation may dismutase product hydrogen peroxide, while it increased
restore NO activity by decreasing oxygen radical forma- the net production of NO (Fig. 3). Although, the levels of
tion. Tetrahydrobiopterin can also improve abnormal endo- H B from SHR were not different when compared to4
thelium-dependent coronary vasomotion in response to Wistar-Kyoto (WKY) aortas, NOS activity in response to
acetylcholine in patients with coronary artery disease [40]. exogenous H B was significantly higher in the latter.4
Furthermore, administration of tetrahydrobiopterin is ca- These results suggest that an increased requirement for
pable of restoring endothelium-dependent vasodilation in H B may trigger an uncoupling of the oxidative and4
experimental diabetes [41], smoking [42,43], and reperfu- reductive domain of the enzyme resulting in dysfunctional
2Fig. 3. Bar graphs showing the basal and calcium ionophore A23187-stimulated concentration of superoxide (O ) and hydrogen peroxide (H O ) in aortic2 2 2
tissue from 4-week old Wistar-Kyoto rats (WKY, top) and spontaneously hypertensive rats (SHR, bottom). Note that after tetrahydrobiopterin (H B)4
G 2
supplementation and in the presence of NOS inhibitor N -monomethyl-L-arginine (L-NMMA) the A23187-induced concentrations of O and its dismutase2
product H O were significantly reduced only in SHR (reprinted from ref. [38]).2 2
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Impaired endothelium-dependent vasodilation in essential hyperten-NOS activity. Whether oxygen free radicals formed via
sion. Circulation 1995;91:1732–1738.NOS plays a role in the development of hypertension [9] Johnstone MT, Creager SJ, Scales KM et al. Impaired endothelium-
remains to be determined. dependent vasodilation in patients with insulin-dependent diabetes.
Circulation 1993;88:2510–2516.
[10] Ting HT, Timimi FK, Boles KS et al. Vitamins C improves
endothelium-dependent vasodilation in patients with non insulin-3. Conclusions
dependent diabetes mellitus. J Clin Invest 1996;97:22–28.
[11] Heitzer TS, Yla-Herttuala S, Luoma J et al. Cigarette smoking
All together these observations strongly support the potentiates endothelial dysfunction of forearm resistance vessels in
concept of a dysfunctional NOS as a new source of patients with hypercholesterolemia. Circulation 1996;93:1346–1353.
[12] Freeman JE, Kuo WY, Drenger B et al. Analysis of lysophos-reactive oxygen metabolites. This NOS-catalyzed forma-
2 phatidylcholine-induced endothelial dysfunction. J Cardiovasc Phar-tion of O and its subsequent transformation into HONOO2
macol 1996;28:345–352.
cleavage products, or its dismutation into H O and Fenton2 2 [13] Bode-Boger SM, Boger RH, Kienke S, Junker W, Frolich JC.
reaction product OH, may play a pivotal role in the Elevated L-arginine /dimethylarginine ratio contributes to enhanced
endothelial dysfunction and oxidative vascular injury systemic NO production by dietary L-arginine in hypercholes-
terolemic rabbits. Biochem Biophys Res Commun 1996;219:598–described in a number of vascular diseases. Therefore,
603.reduced availability of H B may represent an important4 [14] Cooke JP, Tsao PS. Arginine: a new therapy for atherosclerosis?mechanism underlying conditions associated with impaired Circulation 1997;95:311–312.NO activity and accelerated atherosclerosis. Although the [15] Beckman JS, Koppenol WH. Nitric oxide, superoxide, and perox-
background for such a deficiency is not clear, these ynitrite: the good, the bad and the ugly. Am J Physiol
1996;271:C1424–C1437.findings warrant further exploration for a better under-
[16] Kobayashi K, Miki M. A direct demonstration of reaction of nitricstanding of signal transduction pathways sustaining the
oxide with superoxide anion by the use of pulse radiolysis. In:formation of H B in the endothelium. The present knowl-4 Asada K, Yoshikawa T, editors, Frontiers of reactive oxygen species
edge not only underscore the relevance of H B as crucial4 in biology & medicine, Elsevier Science B.V, Amsterdam, 1994, pp.
cofactor for NO synthesis but also may initiate research 223–224.
into new therapeutic approaches to reduce cardiovascular [17] Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry
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